Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin

J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e508-e510. doi: 10.1111/jdv.18055. Epub 2022 Mar 15.

Authors

P R Criado¹, M Ianhez^{2

3}, P S Rocha³, H A Miot⁴

Affiliations

¹ Centro Universitário Faculdade de Medicina do ABC and Alergoskin Alergia e Dermatologia, Santo André, SP, Brazil.
² Universidade Federal de Goiás (UFG) and Cório Clínica de Dermatologia, Goiânia, GO, Brazil.
³ Hospital de Doenças Tropicais, Goiânia, GO, Brazil.
⁴ UNESP Medical School, Botucatu, SP, Brazil.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

COVID-19*
ChAdOx1 nCoV-19
Humans
Isotretinoin / therapeutic use
Pityriasis Rubra Pilaris*

Substances

ChAdOx1 nCoV-19
Isotretinoin